ofloxacin has been researched along with Chlamydia pneumoniae Infections in 3 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The influence of patient relevant parameters such as age, comorbidity, or duration of disease on the treatment success of levofloxacin for community-acquired respiratory tract infections (CARTI) has not been thoroughly elucidated." | 7.72 | The influence of comorbidity on the effect of levofloxacin treatment success of ambulatory respiratory tract infections. ( Burgmann, H; Kumbein, F; Lukas, A; Mayer, B; Oberbauer, R, 2003) |
| "The influence of patient relevant parameters such as age, comorbidity, or duration of disease on the treatment success of levofloxacin for community-acquired respiratory tract infections (CARTI) has not been thoroughly elucidated." | 3.72 | The influence of comorbidity on the effect of levofloxacin treatment success of ambulatory respiratory tract infections. ( Burgmann, H; Kumbein, F; Lukas, A; Mayer, B; Oberbauer, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burgmann, H | 1 |
| Mayer, B | 1 |
| Lukas, A | 1 |
| Kumbein, F | 1 |
| Oberbauer, R | 1 |
| Caronzolo, D | 1 |
| Lucini, V | 1 |
| Pannacci, M | 1 |
| Grosso, S | 1 |
| Colleoni, F | 1 |
| Fraschini, F | 1 |
| Scaglione, F | 1 |
| Saada, D | 1 |
| Velasco, S | 1 |
| Vabres, P | 1 |
| Guillet, G | 1 |
3 other studies available for ofloxacin and Chlamydia pneumoniae Infections
| Article | Year |
|---|---|
The influence of comorbidity on the effect of levofloxacin treatment success of ambulatory respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Child; Child, Preschool; Chlamydo | 2003 |
Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Cell Line; Chlamydophila Inf | 2004 |
[Erythema multiforme majus and Chlamydia pneumoniae infection].
Topics: Acyclovir; Adolescent; Anti-Bacterial Agents; Antiviral Agents; Chlamydophila Infections; Chlamydoph | 2006 |